GILD | Gilead Sciences

Today
2.43
%
$
87.84
Innovation
Growth
Health

About Gilead Sciences

Gilead Sciences is a biopharmaceutical firm with headquarters in Foster City, California. The company makes antiviral drugs for the treatment of HIV, hepatitis B and C and influenza. GILD is also famous for its Covid drug Remdesivir. Learn the latest information and analysis on the company, GILD stock price today, history, stock news, how much one share costs and other information to help you make investment decisions. 

Check Gainy app to see how much the price has changed recently as well as insights on stock prices and more.

Their stock price fell at the beginning of October 2021 and is showing good potential for recovery and future growth. The company is part of the NASDAQ Biotechnology Index and the S&P 500. The GILD stock price is yet to regain its April 2020 level, which may be a good thing for value investors looking for an undervalued stock that has a good potential to grow in the future.

Check back to this page for the GILD stock quote or download Gainy to always have all the key stock info and stock quotes for all the public stocks right in your pocket.

Market Data

Market
Capitalization
$
107.56B
30 days price change
11.94
%
Revenue Growth
Quarterly, YoY
-5.10
%
Volume, Today
5.69M
EV/S
4.71
%
Net Profit Margin
TTM, ANNUAL
12.29%

Ratings

3.69
bullish
Very bullish
Neutral
Bearish
Very Bearish
Very bullish
8
Bullish
5
Neutral
15
Bearish
1
Very Bearish
0
Price Target
$
75.96
Does it work for you
More information in Gainy App
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download on the App Store
Try thematic trading fractional collections! They’re thematic, diversified, built for long-term returns, and they’re right here in our brand new web platform.
Try it now